CREDIT SUISSE AG/ - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 27 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$333,8750.0%360,0000.0%0.00%
Q1 2023$333,875
-84.9%
360,000
-84.7%
0.00%
-100.0%
Q3 2022$2,216,000
+24522.2%
2,350,000
+23400.0%
0.00%
Q2 2022$9,000
-35.7%
10,000
-33.3%
0.00%
Q3 2021$14,000
-99.7%
15,000
-99.7%
0.00%
-100.0%
Q2 2021$4,385,000
+974.8%
4,761,000
+1090.2%
0.00%
Q4 2020$408,000400,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Penn Mutual Asset Management 2,756,000$2,702,7345.74%
Sonora Investment Management Group, LLC 15,741,000$14,824,1651.16%
Fort Baker Capital Management LP 6,735,000$6,569,4280.73%
PALISADE CAPITAL MANAGEMENT, LP 5,486,000$5,348,8500.14%
Kohlberg Kravis Roberts & Co. L.P. 3,921,000$3,874,4480.12%
PINNACLE ASSOCIATES LTD 265,000$258,4100.00%
HighTower Advisors, LLC 2,453,000$2,434,0000.00%
MACQUARIE GROUP LTD 2,435,000$2,406,0000.00%
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 2,500,000$2,431,3750.00%
SCHRODER INVESTMENT MANAGEMENT GROUP 500,000$490,3150.00%
View complete list of IONIS PHARMACEUTICALS INC shareholders